Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Share-based Compensation (2018 - 2025)

Exagen (XGN) has disclosed Share-based Compensation for 8 consecutive years, with $705000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 62.82% year-over-year to $705000.0, compared with a TTM value of $2.2 million through Dec 2025, up 22.4%, and an annual FY2025 reading of $2.2 million, up 22.4% over the prior year.
  • Share-based Compensation was $705000.0 for Q4 2025 at Exagen, up from $593000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $1.4 million in Q2 2022 and bottomed at $217000.0 in Q3 2024.
  • Average Share-based Compensation over 5 years is $848500.0, with a median of $826500.0 recorded in 2023.
  • The sharpest move saw Share-based Compensation crashed 75.62% in 2024, then skyrocketed 173.27% in 2025.
  • Year by year, Share-based Compensation stood at $1.2 million in 2021, then crashed by 50.55% to $582000.0 in 2022, then surged by 31.1% to $763000.0 in 2023, then crashed by 43.25% to $433000.0 in 2024, then soared by 62.82% to $705000.0 in 2025.
  • Business Quant data shows Share-based Compensation for XGN at $705000.0 in Q4 2025, $593000.0 in Q3 2025, and $443000.0 in Q2 2025.